Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes
Articles > Article · 2013
Authors: A. M. D. Watson, Murat OLUKMAN, C KOULİS, Y TU, D SAMİJONO, D. Yuen, C LEE, D. J. Behm, M. E. Cooper, K. A. M. Jandeleit-Dahm, A. C. Calkin, T. J. Allen
DIABETOLOGIA, Journal Indexed in SCI Expanded, International, 2013, vol 56, pp 1155-1165
DOI: 10.1007/s00125-013-2837-9
Summary
Aims/hypothesis The small, highly conserved vasoactive peptide urotensin II (UII) is upregulated in atherosclerosis. However, its effects in diabetes-associated atherosclerosis have not been assessed.